Macrocytic Anemia with Elevated RDW
This patient has macrocytic anemia (MCV 100.6 fL) with elevated RDW (17.4%), indicating a heterogeneous red cell population that most likely represents either vitamin B12/folate deficiency, dimorphic anemia (combined nutritional deficiencies), or early myelodysplastic syndrome—requiring immediate measurement of vitamin B12, folate, serum ferritin, and transferrin saturation.
Laboratory Pattern Analysis
The CBC reveals:
- Anemia: Hemoglobin 9.4 g/dL (low)
- Macrocytosis: MCV 100.6 fL (elevated, normal range ~80-97 fL)
- Elevated RDW: 17.4% (significantly elevated, indicating anisocytosis)
- Normal MCH: 30.2 pg (within normal range)
The combination of macrocytosis with markedly elevated RDW is critical—this is not a uniform macrocytic process.
Differential Diagnosis Priority
Most Likely: Nutritional Deficiency
The elevated RDW distinguishes this from pure vitamin B12/folate deficiency (which typically shows uniform macrocytosis with normal RDW initially). The elevated RDW suggests either:
- Dimorphic anemia (combined B12/folate AND iron deficiency)—the RDW has superior discriminatory ability for detecting mixed nutritional deficiencies 1
- Early or treated nutritional deficiency with mixed cell populations
- Vitamin B12 or folate deficiency alone with reticulocytosis
Alternative Considerations
- Myelodysplastic syndrome: Particularly in older patients, macrocytosis with dysplastic features
- Chronic kidney disease: Though CKD typically causes normocytic anemia 2, evaluate renal function
- Hemolysis with reticulocytosis: Would elevate MCV and RDW
- Alcohol use or liver disease: Common causes of macrocytosis
- Medications: Methotrexate, hydroxyurea, antiretrovirals
Recommended Evaluation Algorithm
Immediate Laboratory Testing
Essential first-line tests 2:
- Vitamin B12 level (most critical)
- Serum folate
- Serum ferritin (assess iron stores)
- Transferrin saturation (TSAT)
- Reticulocyte count (assess bone marrow response)
- Peripheral blood smear (evaluate for:
- Hypersegmented neutrophils (B12/folate deficiency)
- Oval macrocytes vs. round macrocytes
- Dysplastic features
- Mixed cell populations)
Second-line Testing Based on Initial Results
- If ferritin low (<25 ng/mL) or TSAT <20%: Confirms dimorphic anemia 1
- If B12 <200 pg/mL: Add methylmalonic acid and homocysteine for confirmation
- If abnormalities in multiple cell lines (WBC, platelets): Hematology referral for possible bone marrow evaluation 2
- Renal function tests (BUN, creatinine): CKD evaluation 2
- Thyroid function: Hypothyroidism causes macrocytosis
- Liver function tests: Assess for chronic liver disease
Clinical History Focus
Specifically assess for:
- Dietary intake: Vegetarian/vegan diet (B12), poor nutrition (folate)
- Gastrointestinal symptoms: Malabsorption, diarrhea, previous gastric surgery
- Medications: Metformin (B12 malabsorption), anticonvulsants, chemotherapy
- Alcohol consumption: Major cause of macrocytosis
- Bleeding history: Menstrual losses, GI bleeding (suggests iron deficiency component)
- Neurological symptoms: Paresthesias, ataxia, cognitive changes (B12 deficiency)
- Age and comorbidities: Older age increases MDS risk
Critical Clinical Pitfalls
Common Errors to Avoid
Assuming pure macrocytic anemia: The elevated RDW (17.4%) indicates this is NOT a uniform process—do not treat empirically with only B12/folate without checking iron status 1
Missing dimorphic anemia: In populations with high prevalence of nutritional deficiencies, combined iron and B12/folate deficiency is common and can present with microcytic, normocytic, OR macrocytic indices depending on which deficiency predominates 1
Overlooking MDS in older patients: If age >60 years with unexplained macrocytosis and cytopenias, maintain high suspicion for myelodysplastic syndrome
Ignoring the reticulocyte count: A low reticulocyte count with anemia indicates inadequate bone marrow response and narrows the differential significantly 2
Treating without confirming diagnosis: Always obtain B12 and folate levels BEFORE starting replacement therapy, as treatment will obscure the diagnosis
Management Implications
- If B12/folate deficiency confirmed: Initiate appropriate replacement therapy
- If dimorphic anemia: Address BOTH iron and B12/folate deficiencies simultaneously
- If iron deficiency in non-menstruating patient: Evaluate for GI bleeding with endoscopy 2
- If unexplained or refractory: Hematology referral for bone marrow biopsy consideration
The elevated RDW is the key discriminating feature here—it signals heterogeneity that demands comprehensive nutritional assessment rather than assuming a single etiology 1.